Macrophages in Tumor Microenvironments and the Progression of Tumors
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF-β, and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, many other neoplasms are associated with M2-like TAMs that secrete immunosuppressive cytokines that promote tumor growth and metastasis (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, TAMs induce immunosuppression via release of IL-10 and TGF-β, both of which inhibit the development of cytotoxic T cells and NK cells, and may fuel the appearance of more M2-like TAMs at the tumor site (8, 67, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cancer, tumor-associated macrophages (TAMs) have been known to either promote or hinder neoplasia (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
In the citing paper
“In contrast, M2 macrophages (CD163) play an anti-inflammatory and pro-tumor role”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
In the citing paper
“TAMs often exhibit an “M2-like” phenotype [324].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 2×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 4×
“Several studies reporting the use of “antimacrophage” approaches have primarily focused on counteracting monocyte chemokines and receptors as anticancer targets [10, 14, 36, 42].”
BackgroundInfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“, tumor necrosis factor-α (TNF-α)) [6] (Figure 1).”
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 1×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“Finally, M2c macrophages are induced by IL-10, transforming growth factor-β (TGF-β), or glucocorticoids (GCs) [7] (Figure 1).”
BackgroundMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 7×
“M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II.”
BackgroundInfluentialInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“IL-23, which is also secreted by M1 macrophages, is associated with the development and expansion of Th17 cells, which can secrete high levels of IL-17 and contribute to inflammatory autoimmune pathologies [17, 18].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 1×
“Chemokines, such as CCL17 and CCL22, can prevent the infiltration of cytotoxic T-cells but promote that of Treg and Th2 cells [38, 94].”
Background
Research works printed but not linked: 12
- 2008, Journal of Immunology, 15, 3733
- 2002, American Journal of Pathology, 161, 947, 10.1016/s0002-9440(10)64255-1 · DOI · Paper page
- 2005, Oncology Reports, 14, 425
- 1996, Journal of Immunology, 156, 73
- 1997, Journal of Immunology, 159, 770
- 1995, Journal of Immunology, 154, 1280
- 2000, Cancer Research, 60, 2632
- 1999, International Journal of Cancer, 84, 539
- 1984, Annual Review of Immunology, 2, 283, 10.1146/annurev.iy.02.040184.001435 · doi:10.1146/annurev.iy.02.040184.001435 · Paper page
- 2003, Cancer Research, 63, 8360
- 1995, Cancer Research, 55, 1499
- 2003, Cancer Research, 63, 7853
Cited by
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Arango Duque, G., & Descoteaux, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00491 · Cited by 2,708
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
“M2 macrophages are generally considered to be the phenotype of tumor-associated macrophages (TAMs), [454] [455] [456] have immunosuppressive and angiogenesis-promoting effects, and are considered to be a tumor-promoting cell type.”
BackgroundTumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014) · Cancers · doi:10.3390/cancers6031670 · Cited by 1,538
“Other CC chemokines including CCL3, CCL4, CCL5 (RANTES), and CCL22 (macrophage-derived chemokine) and some CXC chemokines, in particular CXCL8, may also be involved in TAM recruitment [6,26,27], because they are highly expressed in many human tumors and various tumor cell lines.”
BackgroundThe Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
“Moreover, TGF-β-secreting cells such as TAMs and tumor cells suppress T cells, NK cells, decline DC migration, and promote CD4+ T cell differentiation into Th2 and Tregs (73).”
BackgroundThe mechanism of action of BCG therapy for bladder cancer--a current perspective
Redelman-Sidi, G., Glickman, M. S., & Bochner, B. H. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.15 · Cited by 729
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Alfarouk, K. O., Stock, C.-M., Taylor, S., Walsh, M., Muddathir, A. K., Verduzco, D., Bashir, A. H. H., Mohammed, O. Y., Elhassan, G. O., Harguindey, S., et al. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0221-1 · Cited by 665
Song, M., Liu, T., Shi, C., Zhang, X., & Chen, X. (2016) · ACS Nano · doi:10.1021/acsnano.5b06779 · Cited by 662
The extracellular matrix in tumor progression and metastasis
Eble, J. A., & Niland, S. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09966-1 · Cited by 613
Essandoh, K., Li, Y., Huo, J., & Fan, G.-C. (2016) · Shock · doi:10.1097/shk.0000000000000604 · Cited by 606
“In contrast, alternative macrophage polarization is characterized by its ability to antagonize prototypic inflammatory responses by helping parasite clearance and promoting tissue remodeling (19).”
BackgroundInfluentialTumor microenvironment participates in metastasis of pancreatic cancer
Ren, B., Cui, M., Yang, G., Wang, H., Feng, M., You, L., & Zhao, Y. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0858-1 · Cited by 589
The macrophage switch in obesity development
Castoldi, A., Naffah de Souza, C., Câmara, N. O. S., & Moraes-Vieira, P. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00637 · Cited by 575
“In turn, M1 macrophages secrete cytokines, including IL-6, TNF-α, IL-1β (39), IL-12, and IL-23 (40).”
Cho, D.-I., Kim, M. R., Jeong, H.-Y., Jeong, H. C., Jeong, M. H., Yoon, S. H., Kim, Y. S., & Ahn, Y. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.135 · Cited by 541
Comito, G., Giannoni, E., Segura, C. P., Barcellos-de-Souza, P., Raspollini, M. R., Baroni, G., Lanciotti, M., Serni, S., & Chiarugi, P. (2014) · Oncogene · doi:10.1038/onc.2013.191 · Cited by 528
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A., & Kaczmarek, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656364 · Cited by 513
Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
Cooks, T., Pateras, I. S., Jenkins, L. M., Patel, K. M., Robles, A. I., Morris, J., Forshew, T., Appella, E., Gorgoulis, V. G., & Harris, C. C. (2018) · Nature Communications · doi:10.1038/s41467-018-03224-w · Cited by 482
Myers, K. V., Amend, S. R., & Pienta, K. J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1022-2 · Cited by 470
Choo, Y. W., Kang, M., Kim, H. Y., Han, J., Kang, S., Lee, J.-R., Jeong, G.-J., Kwon, S. P., Song, S. Y., Go, S., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02446 · Cited by 465
Szulzewsky, F., Pelz, A., Feng, X., Synowitz, M., Markovic, D., Langmann, T., Holtman, I. R., Wang, X., Eggen, B. J. L., Boddeke, H. W. G. M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116644 · Cited by 406
Macrophage polarization and meta-inflammation
Li, C., Xu, M. M., Wang, K., Adler, A. J., Vella, A. T., & Zhou, B. (2018) · Translational Research · doi:10.1016/j.trsl.2017.10.004 · Cited by 370
Navegantes, K. C., de Souza Gomes, R., Pereira, P. A. T., Czaikoski, P. G., Azevedo, C. H. M., & Monteiro, M. C. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1141-8 · Cited by 358
“In this context, IL-10 is secreted by dendritic cells, B cells, cytotoxic T-cells, T-cells, NK cells, mast cells, neutrophils, eosinophils, as well as monocytes/macrophages [55].”
BackgroundMacrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis
Corliss, B. A., Azimi, M. S., Munson, J. M., Peirce, S. M., & Murfee, W. L. (2016) · Microcirculation · doi:10.1111/micc.12259 · Cited by 356
“It is interesting to speculate how the parallel roles that TAMs play in angio- genesis and lymphangiogenesis—in secreting proangiogenic and prolymphangiogenic growth factors and in potentially serving as a source of EPCs—might serve to link these two vessel growth and remodeling processes and offer a thera- peutic tar…”
MethodInfluentialWang, J., Li, D., Cang, H., & Guo, B. (2019) · Cancer Medicine · doi:10.1002/cam4.2327 · Cited by 349
Tumor-associated macrophages: an effective player of the tumor microenvironment
Basak, U., Sarkar, T., Mukherjee, S., Chakraborty, S., Dutta, A., Dutta, S., Nayak, D., Kaushik, S., Das, T., & Sa, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295257 · Cited by 333
“They contribute to angiogenesis, lymphangiogenesis, immunological suppression, hypoxia-induced tumorigenesis, metastasis, and drug resistance, among others (7).”
BackgroundInfluentialM1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds
Wang, Y., Smith, W., Hao, D., He, B., & Kong, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.050 · Cited by 330
Interaction of tumor-associated macrophages and cancer chemotherapy
Larionova, I., Cherdyntseva, N., Liu, T., Patysheva, M., Rakina, M., & Kzhyshkowska, J. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1596004 · Cited by 322
Uterine NK cells and macrophages in pregnancy
Faas, M. M., & de Vos, P. (2017) · Placenta · doi:10.1016/j.placenta.2017.03.001 · Cited by 312
“Also tumors are in fi ltrated by immune cells, mostly Tcells [87], but also NK cells and macrophages [88,89].”
Tumor infiltrating immune cells in gliomas and meningiomas
Domingues, P., González-Tablas, M., Otero, Á., Pascual, D., Miranda, D., Ruiz, L., Sousa, P., Ciudad, J., Gonçalves, J. M., Lopes, M. C., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.07.019 · Cited by 302
Macrophage reaction against biomaterials in the mouse model–phenotypes, functions and markers
Klopfleisch, R. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.07.003 · Cited by 298
Identification of polarized macrophage subsets in zebrafish
Nguyen-Chi, M., Laplace-Builhe, B., Travnickova, J., Luz-Crawford, P., Tejedor, G., Phan, Q. T., Duroux-Richard, I., Levraud, J.-P., Kissa, K., Lutfalla, G., et al. (2015) · eLife · doi:10.7554/elife.07288 · Cited by 297
“…pro-inflammatory cytokines at both 6 and 26 hpA (Figure 3F,G), but expressed high levels of tgfb1, ccr2, and cxcr4b (Figure 3H), that are specifically expressed in mammalian M2 macrophages (Mantovani et al., 2002; Martinez et al., 2006; Hao et al., 2012; Beider et al., 2014; Machado et al., 2014).”
Macrophages, Inflammation, and Lung Cancer
Conway, E. M., Pikor, L. A., Kung, S. H. Y., Hamilton, M. J., Lam, S., Lam, W. L., & Bennewith, K. L. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1545ci · Cited by 286
Portrait of inflammatory response to ionizing radiation treatment
Di Maggio, F. M., Minafra, L., Forte, G. I., Cammarata, F. P., Lio, D., Messa, C., Gilardi, M. C., & Bravatà, V. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0058-3 · Cited by 286
“Furthermore, an increase of cytokines produced by Th2 cells (IL-13, IL-4, IL-5) able to induce the differentiation of “tumour-promoting M2 macrophages” expressing antiinflammatory cytokines, such as TGF-β and IL-10 were described [72,73].”
BackgroundMalyshev, I., & Malyshev, Y. (2015) · BioMed Research International · doi:10.1155/2015/341308 · Cited by 276
“Among them are the following: (1) immune factors, such as immune complexes and cytokines [25]; (2) pathogenassociated molecular patterns (PAMP), such as LPS, microbial nucleic acids, proteins, or carbohydrates that can be recognized by PRR of macrophages; (3) physical and chemical factors, such as hypoxia [26], fever,…”
BackgroundThe role of microglia and myeloid immune cells in acute cerebral ischemia
Benakis, C., Garcia-Bonilla, L., Iadecola, C., & Anrather, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00461 · Cited by 248
“On the other hand, “alternative” or M2 macrophages, induced by interleukin-4 (IL-4), IL-10 or transforming growth factor-β (TGF-β), promote anti-inflammatory and reparative processes (Mantovani et al., 2004; Hao et al., 2012; Yang et al., 2014).”
BackgroundPeña-Romero, A. C., & Orenes-Piñero, E. (2022) · Cancers · doi:10.3390/cancers14071681 · Cited by 257
Targeting T cell metabolism for therapy
O'Sullivan, D., & Pearce, E. L. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.004 · Cited by 254
“M2 macrophages can suppress T cell function and therefore, may support tumor growth [102].”
Vilain, R. E., Menzies, A. M., Wilmott, J. S., Kakavand, H., Madore, J., Guminski, A., Liniker, E., Kong, B. Y., Cooper, A. J., Howle, J. R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0698 · Cited by 245
“19), thereby contributing to immunosuppression (25).”
Fibronectin in Cancer: Friend or Foe
Lin, T.-C., Yang, C.-H., Cheng, L.-H., Chang, W.-T., Lin, Y.-R., & Cheng, H.-C. (2019) · Cells · doi:10.3390/cells9010027 · Cited by 234
“For instance, FN matrix deposition, instead of provisional FN, has been deemed as one of markers in alternatively activated macrophages often designated as M2 macrophages within the pro-tumor inflammatory TMEs [197], whereas it has conversely been revealed that macrophages characteristic of the M1 type responsible for…”
BackgroundLachmann, N., Ackermann, M., Frenzel, E., Liebhaber, S., Brennig, S., Happle, C., Hoffmann, D., Klimenkova, O., Lüttge, D., Buchegger, T., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.01.005 · Cited by 238
“Cells in suspension were harvested twice a week and further differentiated in the presence of M-CSF only, resulting in adherent cells displaying long filopodia typical of M2F (Rey-Giraud et al., 2012; Figure 2B).”
BackgroundInfluentialBrana, I., Calles, A., LoRusso, P. M., Yee, L. K., Puchalski, T. A., Seetharam, S., Zhong, B., de Boer, C. J., Tabernero, J., & Calvo, E. (2015) · Targeted Oncology · doi:10.1007/s11523-014-0320-2 · Cited by 216
“Tumor-associated macrophages alter the surrounding tumor microenvironment [9] and promote tumor progression through metastasis, angiogenesis, and immunosuppression [10].”
BackgroundTiainen, S., Tumelius, R., Rilla, K., Hämäläinen, K., Tammi, M., Tammi, R., Kosma, V., Oikari, S., & Auvinen, P. (2015) · Histopathology · doi:10.1111/his.12607 · Cited by 234
“002 Moderate (26–50%) 11 (8) 5 (4) 10 (7) 6 (5) Strong (51–75%) 57 (42) 38 (27) 60 (43) 32 (24) Very strong (76–100%) 68 (49) 96 (69) 67 (49) 94 (71)”
BackgroundInfluentialMiyake, M., Hori, S., Morizawa, Y., Tatsumi, Y., Nakai, Y., Anai, S., Torimoto, K., Aoki, K., Tanaka, N., Shimada, K., et al. (2016) · Neoplasia · doi:10.1016/j.neo.2016.08.002 · Cited by 228
“TAMs recruited by chemokines such as interleukin (IL)-4 and IL-13 are a major component of the leukocyte infiltrate in tumors [9,10].”
BackgroundThe role of tumor-associated macrophages in tumor immune evasion
Huang, R., Kang, T., & Chen, S. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05777-4 · Cited by 230
“(Hao et al. 2012; Sica and Mantovani 2012).”
Saxena, K., & Jolly, M. K. (2019) · Biomolecules · doi:10.3390/biom9080339 · Cited by 216
Gomez-Roca, C. A., Italiano, A., Le Tourneau, C., Cassier, P. A., Toulmonde, M., D’Angelo, S. P., Campone, M., Weber, K. L., Loirat, D., Cannarile, M. A., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz163 · Cited by 213
“as well as antitumor immunity (M1-like subtype) or that inhibit the anti-inflammatory response, wound healing and have protumorigenic properties (M2-like subtype) [1, 2].”
BackgroundBisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
Van Acker, H. H., Anguille, S., Willemen, Y., Smits, E. L., & Van Tendeloo, V. F. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.008 · Cited by 206
HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation
Nitti, M., Piras, S., Marinari, U., Moretta, L., Pronzato, M., & Furfaro, A. (2017) · Antioxidants · doi:10.3390/antiox6020029 · Cited by 223
Kang, M., Lee, S. H., Kwon, M., Byun, J., Kim, D., Kim, C., Koo, S., Kwon, S. P., Moon, S., Jung, M., et al. (2021) · Advanced Materials · doi:10.1002/adma.202103258 · Cited by 219
Nielsen, M. F. B., Mortensen, M. B., & Detlefsen, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i9.2678 · Cited by 219
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities
Antonioli, L., Yegutkin, G. G., Pacher, P., Blandizzi, C., & Haskó, G. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.01.003 · Cited by 213
“They fall into two distinct subsets: i) classically activated macrophages (M1), expressing a series of pro-inflammatory cytokines, chemokines and effector molecules (i.e IL-12, IL-23, TNF, iNOS and MHCI/II)[48]; and ii) alternatively activated macrophages (M2), expressing a wide array of anti-inflammatory molecules, s…”
BackgroundInfluentialCho, H., Seo, Y., Loke, K. M., Kim, S.-W., Oh, S.-M., Kim, J.-H., Soh, J., Kim, H. S., Lee, H., Kim, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0125 · Cited by 210
“These have been termed "M2-like" TAMs (8), which can promote tumorigenesis by secreting prometastatic cytokines, such as VEGF, IL1b, and EGF (10, 11).”
BackgroundNail, H. M., Chiu, C.-C., Leung, C.-H., Ahmed, M. M. M., & Wang, H.-M. D. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00964-w · Cited by 195
“The inter-play between TAMs and other immune cells, such as T cells and natural killer cells, is crucial in determining the overall immune response against the tumor [128, 132].”
BackgroundMechanisms of Hypoxia-Mediated Immune Escape in Cancer
Barsoum, I. B., Koti, M., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2598 · Cited by 201
Immune system: a double-edged sword in cancer
Lakshmi Narendra, B., Eshvendar Reddy, K., Shantikumar, S., & Ramakrishna, S. (2013) · Inflammation Research · doi:10.1007/s00011-013-0645-9 · Cited by 206
“Heterogeneity and plasticity have emerged as hallmarks of mononuclear phagocytes [29, 30].”
BackgroundTranscriptional Regulation of Macrophages Polarization by MicroRNAs
Li, H., Jiang, T., Li, M.-Q., Zheng, X.-L., & Zhao, G.-J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01175 · Cited by 206
“Proc Natl Acad Sci U S A (2009) 106(13):5282–7.”
Mikuła-Pietrasik, J., Uruski, P., Tykarski, A., & Książek, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2663-1 · Cited by 197
“These cells, in contrast to the M1 fraction bearing pro-inflammatory characteristics, have anti-inflammatory properties associated with the production of various molecules, including IL-10, TGF-β, and arginase 1 [51].”
BackgroundHypoxia-inducible factors: a central link between inflammation and cancer
Triner, D., & Shah, Y. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84430 · Cited by 199
“TAMs inhibit antitumor immune responses through secretion of immunosuppressive cytokines such as IL-10 and TGF-β (77).”
BackgroundInfluentialImage based Machine Learning for identification of macrophage subsets
Rostam, H. M., Reynolds, P. M., Alexander, M. R., Gadegaard, N., & Ghaemmaghami, A. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-03780-z · Cited by 196
“For instance, M1 macrophages can be identified by the production of high levels of pro-inflammatory cytokines such as IL-12, IL-23 6 , IL-1 β , IL-6 and tumour necrosis factor alpha (TNF-α ) 15, 16 .”
BackgroundDiverse functional roles of lipocalin-2 in the central nervous system
Jha, M. K., Lee, S., Park, D. H., Kook, H., Park, K.-G., Lee, I.-K., & Suk, K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.006 · Cited by 195
Obesity and colorectal cancer: Role of adipokines in tumor initiation and progression
Riondino, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5177 · Cited by 193
Macrophages and chemokines as mediators of angiogenesis
Owen, J. L., & Mohamadzadeh, M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00159 · Cited by 192
“Analogous to the T helper cell Th1/Th2 classification, macrophages can be broadly divided into a classically activated M1 phenotype or alternatively activated M2 macrophages (Hao et al., 2012).”
BackgroundFrevert, C. W., Felgenhauer, J., Wygrecka, M., Nastase, M. V., & Schaefer, L. (2018) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417740880 · Cited by 180
“For example, TGF-β promotes the differentiation of macrophages to an M2 or anti-inflammatory phenotype.(151) Thus, TGF-β decreases the NF-kB- and TNF-α production in macrophages by interfering with the TLR2, TLR4, and TLR5 receptors as well as the MyD88 pathway, while TRIFrelated adaptor molecule (TRAM)/TRIF signaling…”
BackgroundKrstic, J., & Santibanez, J. F. (2014) · The Scientific World Journal · doi:10.1155/2014/521754 · Cited by 174
Biological characteristics of IL-6 and related intestinal diseases
Guo, Y., Wang, B., Wang, T., Gao, L., Yang, Z., Wang, F.-F., Shang, H., Hua, R., & Xu, J. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.51362 · Cited by 189
“It is reported that IL-6 secreted by colorectal cancer cells enhance the phagocytic capacity and migration of Mφ using a monocyte-macrophage THP-1 cell model and human peripheral monocytes [120].”
Tariq, M., Zhang, J., Liang, G., Ding, L., He, Q., & Yang, B. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25895 · Cited by 178
The stromal compartments in pancreatic cancer: Are there any therapeutic targets?
Lunardi, S., Muschel, R. J., & Brunner, T. B. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.09.039 · Cited by 176
Huang, J., Ma, L., Song, W., Lu, B., Huang, Y., Dong, H., Ma, X., Zhu, Z., & Zhou, R. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26153 · Cited by 175
Xu, H., Hu, M., Liu, M., An, S., Guan, K., Wang, M., Li, L., Zhang, J., Li, J., & Huang, L. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119769 · Cited by 173
Dendritic cell therapy in cancer treatment; the state-of-the-art
Sadeghzadeh, M., Bornehdeli, S., Mohahammadrezakhani, H., Abolghasemi, M., Poursaei, E., Asadi, M., Zafari, V., Aghebati-Maleki, L., & Shanehbandi, D. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117580 · Cited by 165
He, K.-F., Zhang, L., Huang, C.-F., Ma, S.-R., Wang, Y.-F., Wang, W.-M., Zhao, Z.-L., Liu, B., Zhao, Y.-F., Zhang, W.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/838632 · Cited by 172
“Nowadays, as one of the major components of the microenvironment, tumor-associated macrophages (TAMs, also called tumorinfiltrating macrophages) have been shown to promote tumor progression by influencing tumor invasion, migration, and angiogenesis [11] [12] [13].”
Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma
Tao, W., Chu, C., Zhou, W., Huang, Z., Zhai, K., Fang, X., Huang, Q., Zhang, A., Wang, X., Yu, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16827-z · Cited by 162
Metastasis review: from bench to bedside
Alizadeh, A. M., Shiri, S., & Farsinejad, S. (2014) · Tumor Biology · doi:10.1007/s13277-014-2421-z · Cited by 160
Higashino, N., Koma, Y.-I., Hosono, M., Takase, N., Okamoto, M., Kodaira, H., Nishio, M., Shigeoka, M., Kakeji, Y., & Yokozaki, H. (2019) · Laboratory Investigation · doi:10.1038/s41374-018-0185-6 · Cited by 158
Self‐Activatable Photo‐Extracellular Vesicle for Synergistic Trimodal Anticancer Therapy
Ding, J., Lu, G., Nie, W., Huang, L., Zhang, Y., Fan, W., Wu, G., Liu, H., & Xie, H. (2021) · Advanced Materials · doi:10.1002/adma.202005562 · Cited by 164
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Exploiting macrophages as targeted carrier to guide nanoparticles into glioma
Pang, L., Qin, J., Han, L., Zhao, W., Liang, J., Xie, Z., Yang, P., & Wang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9464 · Cited by 159
Santoni, M., Massari, F., Amantini, C., Nabissi, M., Maines, F., Burattini, L., Berardi, R., Santoni, G., Montironi, R., Tortora, G., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1487-6 · Cited by 161
“In this context, TGF-β1 seems to play a major role during the sarcomatoid transdifferentiation of clear cell RCC [34].”
BackgroundInfluentialKoelzer, V. H., Canonica, K., Dawson, H., Sokol, L., Karamitopoulou, E., Lugli, A., & Zlobec, I. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1106677 · Cited by 156
“The specific polarization of TAM may therefore skew the tumor microenvironment toward tumor rejection (M1) or favor immunotolerance, neoangiogenesis and stromal remodeling (M2).(6) Specific stromal gene expression signatures may render the tumor microenvironment permissible for single cancer cell invasion.”
BackgroundTargeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
Hao, X., Sun, G., Zhang, Y., Kong, X., Rong, D., Song, J., Tang, W., & Wang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.775462 · Cited by 161
Cell Culture in Microfluidic Droplets
Sart, S., Ronteix, G., Jain, S., Amselem, G., & Baroud, C. N. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00666 · Cited by 156
Loomans-Kropp, H. A., & Andl, C. D. (2014) · Cancers · doi:10.3390/cancers7010070 · Cited by 166
“Increased expression of TGF has been noted in various cancers, such as lung, breast and gastric cancers, and has been associated with poor patient prognosis [51,54,55,96,118].”
BackgroundValilou, S. F., Keshavarz‐Fathi, M., Silvestris, N., Argentiero, A., & Rezaei, N. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.01.007 · Cited by 158
Nath, S., Obaid, G., & Hasan, T. G. (2019) · Photochemistry and Photobiology · doi:10.1111/php.13173 · Cited by 154
The Tumor Microenvironment: A Pitch for Multiple Players
Schiavoni, G., Gabriele, L., & Mattei, F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00090 · Cited by 147
“Macrophages represent a significant portion of the tumor mass, and they certainly operate as fundamental actors in various types of solid cancers (Hao et al., 2012).”
BackgroundGranulocyte–macrophage colony-stimulating factor: not just another haematopoietic growth factor
Francisco‐Cruz, A., Aguilar‐Santelises, M., Ramos‐Espinosa, O., Mata‐Espinosa, D., Marquina‐Castillo, B., Barrios‐Payán, J., & Hernández‐Pando, R. (2013) · Medical Oncology · doi:10.1007/s12032-013-0774-6 · Cited by 146
“If tumour growth promotion occurs, it may be rather due to M-CSF stimulation, leading to activation of M2 MØ and other tumour-associated macrophages that produce anti-inflammatory cytokines which are linked to in vivo growth, migration and spreading of a variety of cancers [48, 71].”
BackgroundZhang, Y., Cheng, S., Zhang, M., Zhen, L., Pang, D., Zhang, Q., & Li, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076147 · Cited by 146
“By contrast, for most solid cancers including breast cancer, naturally accumulated TAMs seem to have a dominant M2 phenotype [28,29].”
BackgroundVascular Endothelial Growth Factor (VEGF), Mast Cells and Inflammation
Shaik-Dasthagirisaheb, Y. B., Varvara, G., Murmura, G., Saggini, A., Potalivo, G., Caraffa, A., Antinolfi, P., Tetè, S., Tripodi, D., Conti, F., et al. (2013) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201302600206 · Cited by 146
Teng, Y., Mu, J., Hu, X., Samykutty, A. K., Zhuang, X., Deng, Z., Zhang, L., Cao, P., Yan, J., Miller, D. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8361 · Cited by 145
“As for M1 macrophages, these macrophages produce IL-12 [16, 20– 24] to promote tumoricidal responses.”
Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinic
Agrawal, K., Das, V., Vyas, P., & Hajdúch, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.006 · Cited by 144
Kumar, A., Knops, A. M., Swendseid, B. P., Martinez-Outschoom, U., Harshyne, L. A., Philp, N. J., Rodeck, U., Luginbuhl, A., Cognetti, D. M., Johnson, J. M., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00656 · Cited by 152
“In many tumors, infiltrating macrophages are predominantly of the “alternative” M2-like type, providing an immunosuppressive environment suitable for tumor growth (11).”
BackgroundLi, D., Zhang, Q., Li, L., Chen, K., Yang, J., Dixit, D., Gimple, R. C., Ci, S., Lu, C., Hu, L., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0507 · Cited by 147
Btk Regulates Macrophage Polarization in Response to Lipopolysaccharide
Gabhann, J. N., Hams, E., Smith, S., Wynne, C., Byrne, J. C., Brennan, K., Spence, S., Kissenpfennig, A., Johnston, J. A., Fallon, P. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085834 · Cited by 148
“promoting tumour growth [3], and in the development of allergic”
BackgroundNatural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Wu, L., Wu, W., Zhang, J., Zhao, Z., Li, L., Zhu, M., Wu, M., Wu, F., Zhou, F., Du, Y., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0196 · Cited by 171
“Communication between tumor cells and immune cells plays a pivotal role in tumor progression (8) In particular, the infiltrating macrophages promote tumor angiogenesis, growth, and drug resistance (9) via various cytokine and chemokine release.”
Wu, D., Meng, L., Wang, L.-Y., Lv, G., Cheong, K., Hu, D., Guan, J., Zhao, J., & Li, S. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.04.044 · Cited by 142
Macrophages and prognosis of oral squamous cell carcinoma: A systematic review
Alves, A. M., Diel, L. F., & Lamers, M. L. (2017) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12643 · Cited by 141
“Moreover, M1 functions as an antigen-presenting cell with the potential to play an antitumor role.(11,16) M2 macrophage polarization is stimulated in the presence of IL4, IL-10, IL-13, or TGFb.”
BackgroundRedundant angiogenic signaling and tumor drug resistance
Gacche, R. N., & Assaraf, Y. G. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.01.002 · Cited by 144
Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps
Takabayashi, T., Kato, A., Peters, A. T., Hulse, K. E., Suh, L. A., Carter, R., Norton, J., Grammer, L. C., Tan, B. K., Chandra, R. K., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.02.003 · Cited by 147
Complex role for the immune system in initiation and progression of pancreatic cancer
Inman, K. S., Francis, A. A., & Murray, N. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11160 · Cited by 158
Mechanisms and Consequences of Oxygen and Carbon Dioxide Sensing in Mammals
Cummins, E. P., Strowitzki, M. J., & Taylor, C. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00003.2019 · Cited by 153
“Of interest, skewing the macrophage population to an M2 phenotype plays an important role during wound healing and tumor development (36, 81, 150, 191, 202).”
BackgroundAger, E. I., Kozin, S. V., Kirkpatrick, N. D., Seano, G., Kodack, D. P., Askoxylakis, V., Huang, Y., Goel, S., Snuderl, M., Muzikansky, A., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv017 · Cited by 146
“Typically, tumor-associated macrophages are polarized towards an M2-like state and provide support for tumor growth and progression (27,39).”
BackgroundCellular and molecular mechanisms in cancer immune escape: a comprehensive review
Bhatia, A., & Kumar, Y. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.865519 · Cited by 154
Metadata
- Authors
- Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M.
- Affiliations
- Army Medical University (CN)
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
- Biomedical Analysis Center, Third Military Medical University, Chongqing 40038, China
- Corresponding author
- Zhang, Zhi-Ren
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3385963
- OpenAlex
- W2106027870
- Cited by
- 1,003
- References
- 121
- Citations by year
- 2026: 28 · 2025: 52 · 2024: 79 · 2023: 75 · 2022: 81 · 2021: 109 · 2020: 86 · 2019: 60 · 2018: 65 · 2017: 70 · 2016: 73 · 2015: 85 · 2014: 69 · 2013: 68 · 2012: 2
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31170851, 2010CB529406, 2009BA5045)
- National Basic Research Program of China (31170851, 2010CB529406, 2009BA5045)
- Chongqing Science Fund for Distinguished Young Scholars (31170851, 2010CB529406, 2009BA5045)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, tumor microenvironment, macrophage polarization, M1 macrophages, M2 macrophages, immunosuppression, tumor angiogenesis, metastasis, cancer stem cells, drug resistance, macrophage-targeted therapy
- MeSH terms
- Animals, Humans, Macrophages, Neoplasms, Disease Progression, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.